SELLAS Life Sciences Group, Inc. - Common Stock (SLS)

CUSIP: 81642T209

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / Common Stock
Shares outstanding
178,475,456
Total 13F shares
26,771,579
Share change
+12,473,311
Total reported value
$58,629,839
Put/Call ratio
1.6%
Price per share
$2.19
Number of holders
78
Value change
+$27,498,028
Number of buys
62
Number of sells
13

Security key

81642T209

Report period

Q2 2025

Institutions

78

Top holders

10

Top shareholders of SLS - SELLAS Life Sciences Group, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Anson Funds Management LP
13F
Company
4.2%
7,579,095
$8,185,423 31 Mar 2025
13F
VANGUARD GROUP INC
13F
Company
1.6%
2,839,318
$3,066,464 31 Mar 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.46%
820,440
$886,369 31 Mar 2025
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.39%
688,696
$743,792 31 Mar 2025
13F
BlackRock, Inc.
13F
Company
0.3%
538,460
$581,538 31 Mar 2025
13F
CITADEL ADVISORS LLC
13F
Company
0.2%
349,505
$377,465 31 Mar 2025
13F
STATE STREET CORP
13F
Company
0.16%
277,029
$299,191 31 Mar 2025
13F
Opus Capital Group, LLC
13F
Company
0.13%
239,500
$259,000 31 Mar 2025
13F
NORTHERN TRUST CORP
13F
Company
0.09%
164,390
$177,541 31 Mar 2025
13F
MORGAN STANLEY
13F
Company
0.04%
66,450
$71,766 31 Mar 2025
13F
LPL Financial LLC
13F
Company
0.04%
65,744
$71,004 31 Mar 2025
13F
Atom Investors LP
13F
Company
0.04%
64,216
$69,353 31 Mar 2025
13F
UBS Group AG
13F
Company
0.03%
62,231
$67,210 31 Mar 2025
13F
JANE STREET GROUP, LLC
13F
Company
0.03%
58,541
$63,225 31 Mar 2025
13F
Virtu Financial LLC
13F
Company
0.03%
53,861
$58,000 31 Mar 2025
13F
Mariner, LLC
13F
Company
0.03%
51,200
$55,296 31 Mar 2025
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.03%
48,287
$52,150 31 Mar 2025
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.02%
34,892
$37,683 31 Mar 2025
13F
Jain Global LLC
13F
Company
0.02%
27,400
$29,592 31 Mar 2025
13F
INDEPENDENT FINANCIAL GROUP, LLC
13F
Company
0.01%
23,250
$25,110 31 Mar 2025
13F
GSA CAPITAL PARTNERS LLP
13F
Company
0.01%
22,727
$25,000 31 Mar 2025
13F
Tower Research Capital LLC (TRC)
13F
Company
0.01%
20,889
$22,560 31 Mar 2025
13F
Quadrature Capital Ltd
13F
Company
0.01%
20,673
$22,223 31 Mar 2025
13F
Hudson Bay Capital Management LP
13F
Company
0.01%
20,660
$22,313 31 Mar 2025
13F
Prosperity Financial Group, Inc.
13F
Company
0.01%
16,500
$17,820 31 Mar 2025
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.01%
16,238
$17,537 31 Mar 2025
13F
Grange Capital, LLC
13F
Company
0.01%
13,501
$14,581 31 Mar 2025
13F
TWO SIGMA SECURITIES, LLC
13F
Company
0.01%
12,969
$14,007 31 Mar 2025
13F
ROYAL BANK OF CANADA
13F
Company
0.01%
12,925
$14,000 31 Mar 2025
13F
Schonfeld Strategic Advisors LLC
13F
Company
0.01%
12,481
$13,479 31 Mar 2025
13F
COMMONWEALTH EQUITY SERVICES, LLC
13F
Company
0.01%
12,154
$13,000 31 Mar 2025
13F
Equitable Holdings, Inc.
13F
Company
0.01%
12,060
$13,025 31 Mar 2025
13F
MARSHALL WACE, LLP
13F
Company
0.01%
11,482
$12,401 31 Mar 2025
13F
CALTON & ASSOCIATES, INC.
13F
Company
0.01%
11,000
$11,880 31 Mar 2025
13F
Brooklyn FI, LLC
13F
Company
0.01%
10,140
$10,951 31 Mar 2025
13F
Nemes Rush Group LLC
13F
Company
0.01%
10,000
$10,800 31 Mar 2025
13F
Private Wealth Management Group, LLC
13F
Company
0.01%
10,000
$10,800 31 Mar 2025
13F
SBI Securities Co., Ltd.
13F
Company
0%
5,428
$5,862 31 Mar 2025
13F
WELLS FARGO & COMPANY/MN
13F
Company
0%
3,003
$3,243 31 Mar 2025
13F
OSAIC HOLDINGS, INC.
13F
Company
0%
2,660
$2,872 31 Mar 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
0%
622
$672 31 Mar 2025
13F
JONES FINANCIAL COMPANIES LLLP
13F
Company
0%
374
$415 31 Mar 2025
13F
CALDWELL SUTTER CAPITAL, INC.
13F
Company
0%
100
$108 31 Mar 2025
13F
Parkside Financial Bank & Trust
13F
Company
0%
2
$3 31 Mar 2025
13F
Barbara A. Wood
3/4/5
EVP, Gen. Counsel, Corp. Sec.
mixed-class rows
249,450
mixed-class rows
$821,565 22 Jan 2024
Robert Francomano
3/4/5
Chief Commercial Officer
mixed-class rows
91,836
mixed-class rows
$278,365 22 Jan 2024

Institutional Holders of SELLAS Life Sciences Group, Inc. - Common Stock (SLS) as of Q2 2025

As of 30 Jun 2025, SELLAS Life Sciences Group, Inc. - Common Stock (SLS) was held by 78 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 26,771,579 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock, Inc., MARSHALL WACE, LLP, GEODE CAPITAL MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, MILLENNIUM MANAGEMENT LLC, STATE STREET CORP, MORGAN STANLEY, Nuveen, LLC, and NORTHERN TRUST CORP. This page lists 79 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
43
Q2 2025 holders
78
Holder diff
35
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 Value $ Q2 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .